Altimmune Q1 EPS $(0.40) Beats $(0.48) Estimate, Sales $21.00K Down From $32.00K YoY

Benzinga · 05/11/2023 07:03
Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.48) by 16.67 percent. This is a 9.09 percent increase over losses of $(0.44) per share from the same period last year. The company reported $21.00 thousand in sales this quarter. This is a 34.38 percent decrease over sales of $32.00 thousand the same period last year.